nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—migraine—Prednisone—psoriatic arthritis	0.923	1	CpDpCtD
Cyproheptadine—Neuropathy peripheral—Auranofin—psoriatic arthritis	0.00146	0.019	CcSEcCtD
Cyproheptadine—Jaundice—Auranofin—psoriatic arthritis	0.00145	0.0189	CcSEcCtD
Cyproheptadine—Agranulocytosis—Auranofin—psoriatic arthritis	0.00139	0.0181	CcSEcCtD
Cyproheptadine—Neuritis—Prednisolone—psoriatic arthritis	0.00113	0.0148	CcSEcCtD
Cyproheptadine—Neuritis—Triamcinolone—psoriatic arthritis	0.00104	0.0136	CcSEcCtD
Cyproheptadine—Neuritis—Methylprednisolone—psoriatic arthritis	0.00104	0.0136	CcSEcCtD
Cyproheptadine—Leukopenia—Auranofin—psoriatic arthritis	0.00104	0.0136	CcSEcCtD
Cyproheptadine—Neuritis—Dexamethasone—psoriatic arthritis	0.000946	0.0123	CcSEcCtD
Cyproheptadine—Neuritis—Betamethasone—psoriatic arthritis	0.000946	0.0123	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Auranofin—psoriatic arthritis	0.000928	0.0121	CcSEcCtD
Cyproheptadine—Anorexia—Auranofin—psoriatic arthritis	0.000903	0.0118	CcSEcCtD
Cyproheptadine—Dyspepsia—Auranofin—psoriatic arthritis	0.000834	0.0109	CcSEcCtD
Cyproheptadine—Neuritis—Prednisone—psoriatic arthritis	0.000824	0.0107	CcSEcCtD
Cyproheptadine—Decreased appetite—Auranofin—psoriatic arthritis	0.000824	0.0107	CcSEcCtD
Cyproheptadine—Constipation—Auranofin—psoriatic arthritis	0.00081	0.0106	CcSEcCtD
Cyproheptadine—Wheezing—Triamcinolone—psoriatic arthritis	0.000756	0.00986	CcSEcCtD
Cyproheptadine—Urticaria—Auranofin—psoriatic arthritis	0.000753	0.00982	CcSEcCtD
Cyproheptadine—Euphoric mood—Prednisolone—psoriatic arthritis	0.000727	0.00949	CcSEcCtD
Cyproheptadine—Euphoric mood—Triamcinolone—psoriatic arthritis	0.000669	0.00872	CcSEcCtD
Cyproheptadine—Euphoric mood—Methylprednisolone—psoriatic arthritis	0.000668	0.00871	CcSEcCtD
Cyproheptadine—Increased appetite—Prednisolone—psoriatic arthritis	0.000654	0.00853	CcSEcCtD
Cyproheptadine—Diarrhoea—Auranofin—psoriatic arthritis	0.000648	0.00845	CcSEcCtD
Cyproheptadine—Euphoric mood—Betamethasone—psoriatic arthritis	0.000607	0.00792	CcSEcCtD
Cyproheptadine—Euphoric mood—Dexamethasone—psoriatic arthritis	0.000607	0.00792	CcSEcCtD
Cyproheptadine—Vomiting—Auranofin—psoriatic arthritis	0.000602	0.00786	CcSEcCtD
Cyproheptadine—Increased appetite—Triamcinolone—psoriatic arthritis	0.000602	0.00785	CcSEcCtD
Cyproheptadine—Increased appetite—Methylprednisolone—psoriatic arthritis	0.0006	0.00783	CcSEcCtD
Cyproheptadine—Rash—Auranofin—psoriatic arthritis	0.000597	0.00779	CcSEcCtD
Cyproheptadine—Dermatitis—Auranofin—psoriatic arthritis	0.000597	0.00778	CcSEcCtD
Cyproheptadine—Nausea—Auranofin—psoriatic arthritis	0.000563	0.00734	CcSEcCtD
Cyproheptadine—Increased appetite—Betamethasone—psoriatic arthritis	0.000546	0.00712	CcSEcCtD
Cyproheptadine—Increased appetite—Dexamethasone—psoriatic arthritis	0.000546	0.00712	CcSEcCtD
Cyproheptadine—Irritability—Methylprednisolone—psoriatic arthritis	0.000538	0.00702	CcSEcCtD
Cyproheptadine—Euphoric mood—Prednisone—psoriatic arthritis	0.000529	0.00689	CcSEcCtD
Cyproheptadine—Sweating increased—Prednisolone—psoriatic arthritis	0.000517	0.00675	CcSEcCtD
Cyproheptadine—Irritability—Dexamethasone—psoriatic arthritis	0.000489	0.00638	CcSEcCtD
Cyproheptadine—Irritability—Betamethasone—psoriatic arthritis	0.000489	0.00638	CcSEcCtD
Cyproheptadine—Weight increased—Prednisolone—psoriatic arthritis	0.000483	0.0063	CcSEcCtD
Cyproheptadine—Sweating increased—Triamcinolone—psoriatic arthritis	0.000476	0.00621	CcSEcCtD
Cyproheptadine—Increased appetite—Prednisone—psoriatic arthritis	0.000475	0.0062	CcSEcCtD
Cyproheptadine—Sweating increased—Methylprednisolone—psoriatic arthritis	0.000475	0.00619	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.000464	0.00606	CcSEcCtD
Cyproheptadine—Weight increased—Triamcinolone—psoriatic arthritis	0.000445	0.0058	CcSEcCtD
Cyproheptadine—Weight increased—Methylprednisolone—psoriatic arthritis	0.000444	0.00579	CcSEcCtD
Cyproheptadine—Sweating increased—Dexamethasone—psoriatic arthritis	0.000432	0.00563	CcSEcCtD
Cyproheptadine—Sweating increased—Betamethasone—psoriatic arthritis	0.000432	0.00563	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.000427	0.00557	CcSEcCtD
Cyproheptadine—Irritability—Prednisone—psoriatic arthritis	0.000426	0.00556	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.000426	0.00556	CcSEcCtD
Cyproheptadine—Photosensitivity—Methotrexate—psoriatic arthritis	0.000425	0.00554	CcSEcCtD
Cyproheptadine—Hepatic failure—Methotrexate—psoriatic arthritis	0.000415	0.00542	CcSEcCtD
Cyproheptadine—Weight increased—Dexamethasone—psoriatic arthritis	0.000403	0.00526	CcSEcCtD
Cyproheptadine—Weight increased—Betamethasone—psoriatic arthritis	0.000403	0.00526	CcSEcCtD
Cyproheptadine—Hallucination—Methylprednisolone—psoriatic arthritis	0.000388	0.00506	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000387	0.00505	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000387	0.00505	CcSEcCtD
Cyproheptadine—Sweating increased—Prednisone—psoriatic arthritis	0.000376	0.0049	CcSEcCtD
Cyproheptadine—Irritability—Methotrexate—psoriatic arthritis	0.000356	0.00465	CcSEcCtD
Cyproheptadine—Hallucination—Dexamethasone—psoriatic arthritis	0.000353	0.0046	CcSEcCtD
Cyproheptadine—Hallucination—Betamethasone—psoriatic arthritis	0.000353	0.0046	CcSEcCtD
Cyproheptadine—Weight increased—Prednisone—psoriatic arthritis	0.000351	0.00458	CcSEcCtD
Cyproheptadine—Vision blurred—Prednisolone—psoriatic arthritis	0.000349	0.00455	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000337	0.0044	CcSEcCtD
Cyproheptadine—Vertigo—Prednisolone—psoriatic arthritis	0.000333	0.00434	CcSEcCtD
Cyproheptadine—Syncope—Prednisolone—psoriatic arthritis	0.000332	0.00433	CcSEcCtD
Cyproheptadine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000325	0.00424	CcSEcCtD
Cyproheptadine—Convulsion—Prednisolone—psoriatic arthritis	0.000321	0.00418	CcSEcCtD
Cyproheptadine—Hallucination—Prednisone—psoriatic arthritis	0.000307	0.00401	CcSEcCtD
Cyproheptadine—Vertigo—Triamcinolone—psoriatic arthritis	0.000306	0.00399	CcSEcCtD
Cyproheptadine—Syncope—Triamcinolone—psoriatic arthritis	0.000305	0.00398	CcSEcCtD
Cyproheptadine—Vertigo—Methylprednisolone—psoriatic arthritis	0.000305	0.00398	CcSEcCtD
Cyproheptadine—Syncope—Methylprednisolone—psoriatic arthritis	0.000305	0.00397	CcSEcCtD
Cyproheptadine—Oedema—Prednisolone—psoriatic arthritis	0.000302	0.00394	CcSEcCtD
Cyproheptadine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000299	0.0039	CcSEcCtD
Cyproheptadine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000299	0.00389	CcSEcCtD
Cyproheptadine—Shock—Prednisolone—psoriatic arthritis	0.000297	0.00388	CcSEcCtD
Cyproheptadine—Convulsion—Triamcinolone—psoriatic arthritis	0.000295	0.00385	CcSEcCtD
Cyproheptadine—Tachycardia—Prednisolone—psoriatic arthritis	0.000295	0.00385	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000294	0.00384	CcSEcCtD
Cyproheptadine—Convulsion—Methylprednisolone—psoriatic arthritis	0.000294	0.00384	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000292	0.00381	CcSEcCtD
Cyproheptadine—Drowsiness—Methotrexate—psoriatic arthritis	0.000288	0.00375	CcSEcCtD
Cyproheptadine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000279	0.00364	CcSEcCtD
Cyproheptadine—Oedema—Triamcinolone—psoriatic arthritis	0.000278	0.00362	CcSEcCtD
Cyproheptadine—Vertigo—Betamethasone—psoriatic arthritis	0.000277	0.00362	CcSEcCtD
Cyproheptadine—Vertigo—Dexamethasone—psoriatic arthritis	0.000277	0.00362	CcSEcCtD
Cyproheptadine—Syncope—Dexamethasone—psoriatic arthritis	0.000277	0.00361	CcSEcCtD
Cyproheptadine—Syncope—Betamethasone—psoriatic arthritis	0.000277	0.00361	CcSEcCtD
Cyproheptadine—Shock—Triamcinolone—psoriatic arthritis	0.000273	0.00356	CcSEcCtD
Cyproheptadine—Insomnia—Prednisolone—psoriatic arthritis	0.000273	0.00356	CcSEcCtD
Cyproheptadine—Shock—Methylprednisolone—psoriatic arthritis	0.000273	0.00356	CcSEcCtD
Cyproheptadine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000271	0.00354	CcSEcCtD
Cyproheptadine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000271	0.00354	CcSEcCtD
Cyproheptadine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000271	0.00354	CcSEcCtD
Cyproheptadine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000271	0.00354	CcSEcCtD
Cyproheptadine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000271	0.00353	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000269	0.0035	CcSEcCtD
Cyproheptadine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000268	0.0035	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000268	0.00349	CcSEcCtD
Cyproheptadine—Convulsion—Dexamethasone—psoriatic arthritis	0.000268	0.00349	CcSEcCtD
Cyproheptadine—Convulsion—Betamethasone—psoriatic arthritis	0.000268	0.00349	CcSEcCtD
Cyproheptadine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000259	0.00338	CcSEcCtD
Cyproheptadine—Hepatitis—Methotrexate—psoriatic arthritis	0.000258	0.00337	CcSEcCtD
Cyproheptadine—Vision blurred—Prednisone—psoriatic arthritis	0.000253	0.00331	CcSEcCtD
Cyproheptadine—Oedema—Betamethasone—psoriatic arthritis	0.000252	0.00329	CcSEcCtD
Cyproheptadine—Oedema—Dexamethasone—psoriatic arthritis	0.000252	0.00329	CcSEcCtD
Cyproheptadine—Insomnia—Triamcinolone—psoriatic arthritis	0.000251	0.00328	CcSEcCtD
Cyproheptadine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000251	0.00327	CcSEcCtD
Cyproheptadine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000249	0.00325	CcSEcCtD
Cyproheptadine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000249	0.00325	CcSEcCtD
Cyproheptadine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000249	0.00325	CcSEcCtD
Cyproheptadine—Shock—Betamethasone—psoriatic arthritis	0.000248	0.00323	CcSEcCtD
Cyproheptadine—Shock—Dexamethasone—psoriatic arthritis	0.000248	0.00323	CcSEcCtD
Cyproheptadine—Agitation—Prednisone—psoriatic arthritis	0.000247	0.00322	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000247	0.00322	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000247	0.00322	CcSEcCtD
Cyproheptadine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000246	0.00321	CcSEcCtD
Cyproheptadine—Tachycardia—Betamethasone—psoriatic arthritis	0.000246	0.00321	CcSEcCtD
Cyproheptadine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000245	0.00319	CcSEcCtD
Cyproheptadine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000244	0.00318	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000244	0.00318	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000244	0.00318	CcSEcCtD
Cyproheptadine—Vertigo—Prednisone—psoriatic arthritis	0.000242	0.00315	CcSEcCtD
Cyproheptadine—Syncope—Prednisone—psoriatic arthritis	0.000241	0.00315	CcSEcCtD
Cyproheptadine—Tinnitus—Methotrexate—psoriatic arthritis	0.000241	0.00314	CcSEcCtD
Cyproheptadine—Anorexia—Dexamethasone—psoriatic arthritis	0.00024	0.00313	CcSEcCtD
Cyproheptadine—Anorexia—Betamethasone—psoriatic arthritis	0.00024	0.00313	CcSEcCtD
Cyproheptadine—Urticaria—Prednisolone—psoriatic arthritis	0.00024	0.00313	CcSEcCtD
Cyproheptadine—Fatigue—Triamcinolone—psoriatic arthritis	0.00024	0.00312	CcSEcCtD
Cyproheptadine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000239	0.00312	CcSEcCtD
Cyproheptadine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000236	0.00308	CcSEcCtD
Cyproheptadine—Hypotension—Dexamethasone—psoriatic arthritis	0.000236	0.00307	CcSEcCtD
Cyproheptadine—Hypotension—Betamethasone—psoriatic arthritis	0.000236	0.00307	CcSEcCtD
Cyproheptadine—Convulsion—Prednisone—psoriatic arthritis	0.000233	0.00304	CcSEcCtD
Cyproheptadine—Chills—Methotrexate—psoriatic arthritis	0.000232	0.00302	CcSEcCtD
Cyproheptadine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000229	0.00299	CcSEcCtD
Cyproheptadine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000228	0.00298	CcSEcCtD
Cyproheptadine—Insomnia—Dexamethasone—psoriatic arthritis	0.000228	0.00297	CcSEcCtD
Cyproheptadine—Insomnia—Betamethasone—psoriatic arthritis	0.000228	0.00297	CcSEcCtD
Cyproheptadine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000226	0.00295	CcSEcCtD
Cyproheptadine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000226	0.00295	CcSEcCtD
Cyproheptadine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000222	0.00289	CcSEcCtD
Cyproheptadine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000222	0.00289	CcSEcCtD
Cyproheptadine—Urticaria—Triamcinolone—psoriatic arthritis	0.000221	0.00288	CcSEcCtD
Cyproheptadine—Urticaria—Methylprednisolone—psoriatic arthritis	0.00022	0.00287	CcSEcCtD
Cyproheptadine—Oedema—Prednisone—psoriatic arthritis	0.00022	0.00286	CcSEcCtD
Cyproheptadine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000219	0.00286	CcSEcCtD
Cyproheptadine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000219	0.00286	CcSEcCtD
Cyproheptadine—Fatigue—Dexamethasone—psoriatic arthritis	0.000217	0.00283	CcSEcCtD
Cyproheptadine—Fatigue—Betamethasone—psoriatic arthritis	0.000217	0.00283	CcSEcCtD
Cyproheptadine—Shock—Prednisone—psoriatic arthritis	0.000216	0.00282	CcSEcCtD
Cyproheptadine—Tachycardia—Prednisone—psoriatic arthritis	0.000214	0.00279	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000212	0.00277	CcSEcCtD
Cyproheptadine—Vision blurred—Methotrexate—psoriatic arthritis	0.000212	0.00276	CcSEcCtD
Cyproheptadine—Anorexia—Prednisone—psoriatic arthritis	0.000209	0.00273	CcSEcCtD
Cyproheptadine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000208	0.00271	CcSEcCtD
Cyproheptadine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000208	0.00271	CcSEcCtD
Cyproheptadine—Vertigo—Methotrexate—psoriatic arthritis	0.000202	0.00263	CcSEcCtD
Cyproheptadine—Leukopenia—Methotrexate—psoriatic arthritis	0.000201	0.00262	CcSEcCtD
Cyproheptadine—Urticaria—Betamethasone—psoriatic arthritis	0.0002	0.00261	CcSEcCtD
Cyproheptadine—Urticaria—Dexamethasone—psoriatic arthritis	0.0002	0.00261	CcSEcCtD
Cyproheptadine—Dizziness—Prednisolone—psoriatic arthritis	0.0002	0.00261	CcSEcCtD
Cyproheptadine—Asthenia—Triamcinolone—psoriatic arthritis	0.000199	0.0026	CcSEcCtD
Cyproheptadine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000199	0.00259	CcSEcCtD
Cyproheptadine—Insomnia—Prednisone—psoriatic arthritis	0.000199	0.00259	CcSEcCtD
Cyproheptadine—Paraesthesia—Prednisone—psoriatic arthritis	0.000197	0.00257	CcSEcCtD
Cyproheptadine—Convulsion—Methotrexate—psoriatic arthritis	0.000195	0.00254	CcSEcCtD
Cyproheptadine—Dyspepsia—Prednisone—psoriatic arthritis	0.000193	0.00252	CcSEcCtD
Cyproheptadine—Decreased appetite—Prednisone—psoriatic arthritis	0.000191	0.00249	CcSEcCtD
Cyproheptadine—Rash—Prednisolone—psoriatic arthritis	0.00019	0.00248	CcSEcCtD
Cyproheptadine—Dermatitis—Prednisolone—psoriatic arthritis	0.00019	0.00248	CcSEcCtD
Cyproheptadine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00019	0.00247	CcSEcCtD
Cyproheptadine—Fatigue—Prednisone—psoriatic arthritis	0.000189	0.00247	CcSEcCtD
Cyproheptadine—Headache—Prednisolone—psoriatic arthritis	0.000189	0.00247	CcSEcCtD
Cyproheptadine—Constipation—Prednisone—psoriatic arthritis	0.000188	0.00245	CcSEcCtD
Cyproheptadine—Confusional state—Methotrexate—psoriatic arthritis	0.000185	0.00241	CcSEcCtD
Cyproheptadine—Dizziness—Triamcinolone—psoriatic arthritis	0.000184	0.0024	CcSEcCtD
Cyproheptadine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000183	0.00239	CcSEcCtD
Cyproheptadine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000181	0.00236	CcSEcCtD
Cyproheptadine—Asthenia—Dexamethasone—psoriatic arthritis	0.000181	0.00236	CcSEcCtD
Cyproheptadine—Asthenia—Betamethasone—psoriatic arthritis	0.000181	0.00236	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00018	0.00234	CcSEcCtD
Cyproheptadine—Nausea—Prednisolone—psoriatic arthritis	0.000179	0.00234	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000177	0.00231	CcSEcCtD
Cyproheptadine—Vomiting—Triamcinolone—psoriatic arthritis	0.000177	0.0023	CcSEcCtD
Cyproheptadine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000176	0.0023	CcSEcCtD
Cyproheptadine—Rash—Triamcinolone—psoriatic arthritis	0.000175	0.00228	CcSEcCtD
Cyproheptadine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000175	0.00228	CcSEcCtD
Cyproheptadine—Anorexia—Methotrexate—psoriatic arthritis	0.000175	0.00228	CcSEcCtD
Cyproheptadine—Rash—Methylprednisolone—psoriatic arthritis	0.000175	0.00228	CcSEcCtD
Cyproheptadine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000175	0.00228	CcSEcCtD
Cyproheptadine—Urticaria—Prednisone—psoriatic arthritis	0.000174	0.00227	CcSEcCtD
Cyproheptadine—Headache—Triamcinolone—psoriatic arthritis	0.000174	0.00227	CcSEcCtD
Cyproheptadine—Headache—Methylprednisolone—psoriatic arthritis	0.000174	0.00226	CcSEcCtD
Cyproheptadine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000172	0.00225	CcSEcCtD
Cyproheptadine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000172	0.00225	CcSEcCtD
Cyproheptadine—Hypotension—Methotrexate—psoriatic arthritis	0.000171	0.00224	CcSEcCtD
Cyproheptadine—Dizziness—Betamethasone—psoriatic arthritis	0.000167	0.00217	CcSEcCtD
Cyproheptadine—Dizziness—Dexamethasone—psoriatic arthritis	0.000167	0.00217	CcSEcCtD
Cyproheptadine—Insomnia—Methotrexate—psoriatic arthritis	0.000166	0.00216	CcSEcCtD
Cyproheptadine—Nausea—Triamcinolone—psoriatic arthritis	0.000165	0.00215	CcSEcCtD
Cyproheptadine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000165	0.00215	CcSEcCtD
Cyproheptadine—Nausea—Methylprednisolone—psoriatic arthritis	0.000165	0.00215	CcSEcCtD
Cyproheptadine—Somnolence—Methotrexate—psoriatic arthritis	0.000163	0.00213	CcSEcCtD
Cyproheptadine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000161	0.00211	CcSEcCtD
Cyproheptadine—Vomiting—Betamethasone—psoriatic arthritis	0.00016	0.00209	CcSEcCtD
Cyproheptadine—Vomiting—Dexamethasone—psoriatic arthritis	0.00016	0.00209	CcSEcCtD
Cyproheptadine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000159	0.00208	CcSEcCtD
Cyproheptadine—Rash—Dexamethasone—psoriatic arthritis	0.000159	0.00207	CcSEcCtD
Cyproheptadine—Rash—Betamethasone—psoriatic arthritis	0.000159	0.00207	CcSEcCtD
Cyproheptadine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000159	0.00207	CcSEcCtD
Cyproheptadine—Dermatitis—Betamethasone—psoriatic arthritis	0.000159	0.00207	CcSEcCtD
Cyproheptadine—Fatigue—Methotrexate—psoriatic arthritis	0.000158	0.00206	CcSEcCtD
Cyproheptadine—Headache—Betamethasone—psoriatic arthritis	0.000158	0.00206	CcSEcCtD
Cyproheptadine—Headache—Dexamethasone—psoriatic arthritis	0.000158	0.00206	CcSEcCtD
Cyproheptadine—Asthenia—Prednisone—psoriatic arthritis	0.000157	0.00205	CcSEcCtD
Cyproheptadine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000151	0.00197	CcSEcCtD
Cyproheptadine—Diarrhoea—Prednisone—psoriatic arthritis	0.00015	0.00196	CcSEcCtD
Cyproheptadine—Nausea—Betamethasone—psoriatic arthritis	0.00015	0.00195	CcSEcCtD
Cyproheptadine—Nausea—Dexamethasone—psoriatic arthritis	0.00015	0.00195	CcSEcCtD
Cyproheptadine—Urticaria—Methotrexate—psoriatic arthritis	0.000146	0.0019	CcSEcCtD
Cyproheptadine—Dizziness—Prednisone—psoriatic arthritis	0.000145	0.00189	CcSEcCtD
Cyproheptadine—Vomiting—Prednisone—psoriatic arthritis	0.00014	0.00182	CcSEcCtD
Cyproheptadine—Rash—Prednisone—psoriatic arthritis	0.000138	0.00181	CcSEcCtD
Cyproheptadine—Dermatitis—Prednisone—psoriatic arthritis	0.000138	0.0018	CcSEcCtD
Cyproheptadine—Headache—Prednisone—psoriatic arthritis	0.000138	0.00179	CcSEcCtD
Cyproheptadine—Asthenia—Methotrexate—psoriatic arthritis	0.000132	0.00172	CcSEcCtD
Cyproheptadine—Nausea—Prednisone—psoriatic arthritis	0.00013	0.0017	CcSEcCtD
Cyproheptadine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000126	0.00164	CcSEcCtD
Cyproheptadine—Dizziness—Methotrexate—psoriatic arthritis	0.000121	0.00158	CcSEcCtD
Cyproheptadine—Vomiting—Methotrexate—psoriatic arthritis	0.000117	0.00152	CcSEcCtD
Cyproheptadine—Rash—Methotrexate—psoriatic arthritis	0.000116	0.00151	CcSEcCtD
Cyproheptadine—Dermatitis—Methotrexate—psoriatic arthritis	0.000116	0.00151	CcSEcCtD
Cyproheptadine—Headache—Methotrexate—psoriatic arthritis	0.000115	0.0015	CcSEcCtD
Cyproheptadine—Nausea—Methotrexate—psoriatic arthritis	0.000109	0.00142	CcSEcCtD
